Germany· DE-A57-1058b924682d725c
Abacavir/Lamivudin Al
A medicinal product containing abacavir, lamivudine, registered in Germany by Aliud Pharma Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Abacavir, Lamivudine
- Manufacturer
- Aliud Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Abacavir, lamivudine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainABACAVIR/LAMIVUDINA ACCORD 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- United KingdomAbacavir 600mg / Lamivudine 300mg tabletsDr Reddy's Laboratories (UK) Ltd
- FinlandAbacavir/Lamivudin MylanParanova Oy
- FranceABACAVIR/LAMIVUDINE ACCORD 600 mg/300 mg, comprimé pelliculéACCORD HEALTHCARE FRANCE
- NetherlandsAbacavir/Lamivudine Accord 600 mg/300 mg, filmomhulde tablettenAccord Healthcare B.V.
- United StatesAbacavir and LamivudineMacleods Pharmaceuticals Limited
- SwedenAbacavir/Lamivudine Accord 600 mg/300 mg Filmdragerad tablettAccord Healthcare B.V.
- CanadaAPO-ABACAVIR-LAMIVUDINEAPOTEX INC
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Abacavir/Lamivudin Ratiopharm, Abacavir/Lamivudin Sandoz
- Belgium · Abacavir/Lamivudine Viatris
- Bulgaria · Abacavir/Lamivudine Viatris, Абакавир/Ламивудин Майлан
- Cyprus · Kivala
- Denmark · Abacavir/Lamivudin Medical Valley, Abacavir/Lamivudin Mylan
- Estonia · Abacavir/Lamivudine Auxilia, Abacavir/Lamivudine Mylan
- Spain · Abacavir/Lamivudina Aurovitas, Abacavir/Lamivudina Dr. Reddys
- Finland · Abacavir/Lamivudin Mylan, Abacavir/Lamivudin Viatris
- France · Abacavir / Lamivudine Biogaran, Abacavir/Lamivudine Arrow
- United Kingdom (Northern Ireland) · Abacavir/Lamivudin Sandoz, Abacavir/Lamivudine Accord
- Greece · Abacavir+lamivudine Mylan Pharma, Varistren
- Hungary · Abacavir/Lamivudine Teva
- Ireland · Abacavir/Lamivudine Mylan, Abacavir/Lamivudine Viatris
- Iceland · Kivexa
- Italy · Abacavir E Lamivudina Aurobindo, Abacavir E Lamivudina Sun
- Liechtenstein · Kivexa
- Lithuania · Abacavir / Lamivudine Auxilia, Abacavir/Lamivudine Accord
- Luxembourg · Abacavir/Lamivudine Viatris
- Latvia · Abacavir/Lamivudine Accord, Abacavir/Lamivudine Mylan
- Netherlands · Abacavir Sulfate / Lamivudine Aurobindo, Abacavir/Lamivudin Teva
- Norway · Abacavir/Lamivudin Mylan, Abacavir/Lamivudine Viatris
- Poland · Abacavir + Lamivudine Sandoz
- Portugal · Abacavir + Lamivudina Aurovitas, Abacavir + Lamivudina Farmoz
- Romania · Abacavir/Lamivudină, Abacavir/Lamivudină Mylan
- Sweden · Abacavir/Lamivudine Accord, Abacavir/Lamivudine Glenmark
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3d02983c-fe73-435c-acf6-ce348a9c0030 GET /v1/drugs/3d02983c-fe73-435c-acf6-ce348a9c0030?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Abacavir, Lamivudine",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about abacavir, lamivudine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.